Cargando…

Prediction analysis of porcine AXL protein as a potential receptor for SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Zeng, Chuan, Ye, Zaijiao, Fu, Ling, Ye, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717698/ https://www.ncbi.nlm.nih.gov/pubmed/34974055 http://dx.doi.org/10.1016/j.jinf.2021.12.038

Ejemplares similares

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2
por: Luan, Junwen, et al.
Publicado: (2020)

Is There any Alternative Receptor for SARS-CoV-2?
por: Shahriari Felordi, Mahtab, et al.
Publicado: (2021)

Re: Profile of specific antibodies to SARS-CoV-2: The first report
por: Zeng, Zhikun, et al.
Publicado: (2020)

Predictive Analysis of Susceptibility of Different Species to SARS-CoV-2 based on ACE2 Receptors
por: XU, Xiao Gang, et al.
Publicado: (2020)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

Potential drawbacks of SARS-CoV-2 seroprevalence surveys
por: Lippi, G.
Publicado: (2021)

AXL is not essential for Zika virus infection in the mouse brain
por: Li, Feng, et al.
Publicado: (2017)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy
por: Gengler, Carole, et al.
Publicado: (2021)

Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection
por: Alvarez Bravo, G., et al.
Publicado: (2020)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
por: Nobile, B., et al.
Publicado: (2020)

SARS-CoV-2: a potential novel etiology of fulminant myocarditis
por: Chen, Chen, et al.
Publicado: (2020)

Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders
por: Pieroni, Maurizio, et al.
Publicado: (2021)

Lingonberry polyphenols: Potential SARS‐CoV‐2 inhibitors as nutraceutical tools?
por: Pärnänen, Pirjo, et al.
Publicado: (2021)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease
por: Monteleone, Giovanni, et al.
Publicado: (2020)

SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies()
por: Pérez Álvarez, Á.I., et al.
Publicado: (2020)

Differential roles of RIG-I like receptors in SARS-CoV-2 infection
por: Yang, Duo-Meng, et al.
Publicado: (2021)

Nonpharmaceutical intervention is an effective measure to block respiratory virus coinfections with SARS-CoV-2
por: Ru, Xuanwen, et al.
Publicado: (2023)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

Peptide Targets to SARS-CoV-2
por: Mandal, Santi M.
Publicado: (2020)

On aerosol transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2021)

Living evidence for SARS-CoV-2()
por: Santillan-Garcia, A.
Publicado: (2021)

Is SARS-CoV-2 an oncogenic virus?
por: Gómez-Carballa, Alberto, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Routes of transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Co-infection of MERS-CoV and SARS-CoV-2 in the same host: A silent threat
por: Baddal, Buket, et al.
Publicado: (2020)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Pavoni, Vittorio, et al.
Publicado: (2020)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

The continuum of SARS-CoV-2's neurotropism and the potential for immune-mediated neuronal injury
por: Vavougios, George D.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dv4acn8qc75k8ab00ll6srpe6r